Post-Acute Home Health Care for Veterans: Examining Payer Source, Quality, and Outcomes
Post-Acute Home Health Care for Veterans: Examining Payer Source, Quality, and Outcomes
批准号:
10426941
负责人:
Stefan Gravenstein
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-01 至 2026-09-30
关键词:
AcuteAdmission activityAffectAmericasAreaCaregiversCaringCharacteristicsCollaborationsCommunitiesComplexContractsDataDevelopmentDiscipline of NursingEffectivenessEnrollmentFoundationsFundingGeriatricsGoalsGrowthHealthHealth PersonnelHealth PolicyHealthcareHomeHome Care ServicesHome Health AgencyHome Health Care AgenciesHospitalizationHospitalsHuman ResourcesIndependent LivingInterviewKnowledgeLeadershipLong-Term CareMeasuresMediatingMedical centerMedicareMethodologyMethodsMissionModelingNursing HomesOutcomePathway interactionsPatternPersonal SatisfactionPoliciesProcessProviderQualitative ResearchQuality of CareRecommendationResearchResearch DesignResearch MethodologyResourcesRiskServicesShapesSite VisitSocial WorkSourceStructureTechniquesTestingVeteransWorkadverse outcomecare coordinationcare outcomescare systemscostexperiencehealth care cost/financinghealth care referralhealth care servicehealth care service utilizationhigh riskhigh risk populationhospital readmissionimprovedimproved functioninginnovationinsightmortalitypatient home carepatient populationprimary outcomeprovider networksreadmission ratesservice deliveryshared decision makingstakeholder perspectivestool
中文摘要
项目总结/文摘
英文摘要
PROJECT SUMMARY/ABSTRACT
Background. Veterans are at increased risk of adverse outcomes after hospital discharge, including
rehospitalization, nursing home admission, and mortality. Post-acute skilled home health care (HHC) can
provide critical support for Veterans following a hospitalization. The services provided through HHC, including
nursing and therapies, can help Veterans meet their goals to improve function, well-being, and return to
independent living in their homes. For Medicare-eligible Veterans, skilled HHC is provided through 1) VA
purchased skilled HHC from a contracted HHC agency or 2) Medicare-funded HHC (i.e., Part A benefit,
Medicare Advantage). Preliminary work suggests that the majority (66%) of Veterans discharged home from
VA Medical Centers (VAMCs) with skilled HHC receive VA-contracted skilled HHC and the remainder receive
Medicare-funded HHC. However, funding for skilled HHC varies substantially across VAMCs, with implications
both for HHC service delivery and Veterans’ outcomes. In preliminary work, we found that 30-day readmissions
are higher among Veterans who receive VA-financed HHC compared to Medicare-financed HHC, which could
be related to HHC agency quality.
Significance/Impact. A better understanding of HHC referrals and financing, which has always been
purchased and delivered by community HHC agencies, could provide key insights for the VA given the growth
in community care for Veterans. Because community home health agencies have always provided post-acute
HHC, this context provides an ideal opportunity to examine interorganizational partnerships and Veterans’
outcomes. The proposed research will characterize post-acute HHC use, financing, and quality of care, and
how these factors are associated with outcomes for Veterans discharged from VAMCs, as well as providers’
and Veterans’ experiences of delivering and receiving post-acute HHC. Findings will inform the development of
a toolkit for VA and HHC leaders with resources to guide high-value HHC agency selection and collaboration.
The contribution of this research is significant because the results will directly inform how operational partners
choose HHC agencies to include in provider networks and develop policy for skilled HHC referrals, and will
also provide practical tools for multiple stakeholders to provide optimal HHC for Veterans.
Innovation. This is the first comprehensive study to examine VA contracting, referral practices, and financing -
including both VA and Medicare - to understand their influence on Veterans’ outcomes. A stakeholder-
engaged, complex mixed-methods study design is used to understand the mechanisms and processes that
shape the use and outcomes of post-acute HHC from multiple perspectives.
Specific Aims. 1) Identify determinants of VA vs Medicare-financed post-acute skilled HHC among community
dwelling Medicare-enrolled Veterans; 2) Understand multiple stakeholders’ perspectives on older Veterans’
use of post-acute skilled HHC and factors that influence the delivery of HHC; 3) Determine the impact of home
health agency quality and HHC payer source on differences in outcomes for older Veterans receiving post-
acute HHC.
Methodology. This proposal uses a complex mixed-methods study design with advanced statistical
techniques and comprehensive VA and Medicare administrative data, as well as a robust qualitative approach
to interview stakeholders from VAMCs, HHC agencies, Veterans, and caregivers to accomplish our aims.
Implementation/Next Steps. The culmination of findings from this work will be incorporated into a toolkit to
promote high-value HHC selection and collaboration. In addition, this work will form the foundation for a large-
scale study to develop and test implementation and effectiveness of a shared decision-making model for
Veterans and VAMC personnel to promote high-value HHC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GERIATRIC LEADERSHIP AWARD
-
批准号:6532414
-
项目类别:
-
资助金额:$8.64万
-
财政年份:1998
-
负责人:Stefan Gravenstein
-
依托单位:
GERIATRIC LEADERSHIP AWARD
-
批准号:2563876
-
项目类别:
-
资助金额:$8.63万
-
财政年份:1998
-
负责人:Stefan Gravenstein
-
依托单位:
GERIATRIC LEADERSHIP AWARD
-
批准号:6167929
-
项目类别:
-
资助金额:$8.64万
-
财政年份:1998
-
负责人:Stefan Gravenstein
-
依托单位:
GERIATRIC LEADERSHIP AWARD
-
批准号:6055342
-
项目类别:
-
资助金额:$8.63万
-
财政年份:1998
-
负责人:Stefan Gravenstein
-
依托单位:
GERIATRIC LEADERSHIP AWARD
-
批准号:6371951
-
项目类别:
-
资助金额:$8.64万
-
财政年份:1998
-
负责人:Stefan Gravenstein
-
依托单位:
ANTIBODY DIVERSITY, AGE AND INFLUENZA VACCINE EFFICACY
-
批准号:2423480
-
项目类别:
-
资助金额:$4.59万
-
财政年份:1996
-
负责人:Stefan Gravenstein
-
依托单位:
ANTIBODY DIVERSITY, AGE AND INFLUENZA VACCINE EFFICACY
-
批准号:2048297
-
项目类别:
-
资助金额:$3.64万
-
财政年份:1992
-
负责人:Stefan Gravenstein
-
依托单位:
STUDY SECTION CHAIRMANS FUND (NIH)
-
批准号:6455326
-
项目类别:
-
资助金额:$65.43万
-
财政年份:1992
-
负责人:Stefan Gravenstein
-
依托单位:
STUDY SECTION CHAIRMANS FUND (NIH)
-
批准号:2878193
-
项目类别:
-
资助金额:$75.0万
-
财政年份:1992
-
负责人:Stefan Gravenstein
-
依托单位:
ANTIBODY DIVERSITY, AGE AND INFLUENZA VACCINE EFFICACY
-
批准号:3078732
-
项目类别:
-
资助金额:$8.11万
-
财政年份:1992
-
负责人:Stefan Gravenstein
-
依托单位:
ANTIBODY DIVERSITY, AGE AND INFLUENZA VACCINE EFFICACY
-
批准号:3078733
-
项目类别:
-
资助金额:$8.11万
-
财政年份:1992
-
负责人:Stefan Gravenstein
-
依托单位:
STUDY SECTION CHAIRMANS FUND (NIH)
-
批准号:6611876
-
项目类别:
-
资助金额:$15.5万
-
财政年份:1992
-
负责人:Stefan Gravenstein
-
依托单位:
ANTIBODY DIVERSITY, AGE AND INFLUENZA VACCINE EFFICACY
-
批准号:2048295
-
项目类别:
-
资助金额:$8.21万
-
财政年份:1992
-
负责人:Stefan Gravenstein
-
依托单位:
STUDY SECTION CHAIRMANS FUND (NIH)
-
批准号:2677258
-
项目类别:
-
资助金额:$20.0万
-
财政年份:1992
-
负责人:Stefan Gravenstein
-
依托单位:
STUDY SECTION CHAIRMANS FUND (NIH)
-
批准号:6293674
-
项目类别:
-
资助金额:$56.0万
-
财政年份:1992
-
负责人:Stefan Gravenstein
-
依托单位:
STUDY SECTION CHAIRMANS FUND (NIH)
-
批准号:2666026
-
项目类别:
-
资助金额:$62.76万
-
财政年份:1992
-
负责人:Stefan Gravenstein
-
依托单位:
ANTIBODY DIVERSITY, AGE AND INFLUENZA VACCINE EFFICACY
-
批准号:2048296
-
项目类别:
-
资助金额:$8.28万
-
财政年份:1992
-
负责人:Stefan Gravenstein
-
依托单位:
USE OF AMANTADINE IN THE NURSING HOME
-
批准号:3121530
-
项目类别:
-
资助金额:$20.86万
-
财政年份:1991
-
负责人:Stefan Gravenstein
-
依托单位:
AMANTADINE IN THE NURSING HOME
-
批准号:2050913
-
项目类别:
-
资助金额:$21.97万
-
财政年份:1991
-
负责人:Stefan Gravenstein
-
依托单位:
AMANTADINE IN THE NURSING HOME
-
批准号:2050914
-
项目类别:
-
资助金额:$16.5万
-
财政年份:1991
-
负责人:Stefan Gravenstein
-
依托单位: